France Digital Therapeutics/DTx Market (2026-2031)
The France Digital Therapeutics/DTx Market was valued at $587.5 Million in 2026 and projected to reach to $2096.5 Million by 2031, representing a compound annual growth rate of 29.0%. France's digital therapeutics market is positioned for exceptional growth, driven by the country's commitment to healthcare innovation and digital transformation.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
France Digital Therapeutics/DTx Market Trends and Insights
- This represents a compound annual growth rate of 29.0%, significantly outpacing global averages and reflecting France's strong commitment to healthcare innovation and digital health adoption.
- France's advanced healthcare infrastructure, coupled with increasing regulatory support and reimbursement pathways, positions the country as a key growth hub for DTx solutions across Europe. The French market is driven by rising prevalence of chronic diseases, growing smartphone penetration, and heightened demand for remote patient monitoring solutions.
- France's healthcare system, characterized by robust public funding and progressive digital health policies, creates favorable conditions for DTx deployment across mental health, cardiovascular, and metabolic disorder management.
- Between 2026 and 2031, France is expected to witness accelerated adoption of prescription digital therapeutics, supported by clinical validation and integration into standard care pathways. France's competitive landscape includes both established digital health players and emerging DTx innovators, with increasing collaboration between pharmaceutical companies, healthcare providers, and technology firms.
- The market's trajectory reflects France's strategic positioning within the European digital health ecosystem and its emphasis on evidence-based digital medicine adoption..
Key Market Statistics
- CAGR (2026-2031) 29.0% CAGR
- Market Size, 2026 ~USD 587.5 Million
- Forecast, 2031 ~USD 2096.5 Million
- Country France
France Digital Therapeutics/DTx Market Overview
Exceptional Growth Trajectory :
France's digital therapeutics market is projected to grow from $587.5 million in 2026 to $2,096.5 million by 2031, representing a 29% CAGR—significantly outpacing the global average of 26.4%.
Advanced Healthcare Infrastructure :
France's robust healthcare system and strong digital health adoption create an ideal environment for DTx innovation, supported by government initiatives and favorable regulatory frameworks for digital health solutions.
Market Expansion Drivers :
Rising chronic disease prevalence, increasing healthcare costs, and growing patient demand for remote care solutions are accelerating DTx adoption across France's healthcare ecosystem.
Strategic Investment Opportunity :
With a 3.5x market expansion expected over five years, France represents a high-potential market for DTx developers, healthcare providers, and digital health investors seeking European growth.
France Digital Therapeutics/DTx Market Dynamics
- The 29% CAGR reflects strong adoption of DTx solutions across chronic disease management, mental health, and preventive care segments.
- Government support for digital health initiatives and reimbursement pathways are creating favorable conditions for market expansion.
- By 2031, France is expected to become a leading DTx market in Europe, with increasing integration of digital therapeutics into standard clinical practice and growing patient acceptance of technology-enabled treatments..
Market Ecosystem
DIGITAL THERAPEUTICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
AI-enabled virtual care, chronic disease management, remote patient monitoring (RPM), and integrated digital therapeutics platform | Improved patient engagement, reduced hospitalizations, enhanced chronic disease outcomes, and expanded access to virtual care |
 |
AI-powered behavior change platform, digital weight management, nutrition coaching, and personalized lifestyle interventions | Sustainable weight loss, improved metabolic health, higher patient adherence, and reduced risk of chronic diseases |
 |
AI-driven musculoskeletal (MSK) digital therapy, wearable-enabled motion tracking, computer vision, and virtual physical therapy | Faster recovery, reduced pain, lower musculoskeletal treatment costs, and decreased need for surgery or opioid use |
 |
Digital chronic disease prevention and management platform for diabetes, hypertension, obesity, and cardiovascular health using connected devices and personalized coaching | Improved clinical outcomes, better disease control, increased medication adherence, and reduced healthcare expenditures |
 |
AI-powered digital therapeutics platform integrating glucose monitoring, blood pressure monitoring, behavioral health, and personalized coaching | Better disease self-management, improved patient outcomes, enhanced engagement, and lower total cost of care |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Healthcare Analytics
- Machine Learning
- Natural Language Processing (NLP)
- Blood Pressure Monitors
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Oracle Corporation
- PHILIPS HEALTHCARE
- Siemens healthineers
- Zensar Technologies Limited
- EPIC SYSTEMS CORPORATION
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Key Takeaways
- France's DTx market will grow from $587.5M (2026) to $2,096.5M (2031) at a 29.0% CAGR, outpacing global growth rates.
- France's advanced healthcare infrastructure and progressive reimbursement policies accelerate DTx adoption across chronic disease management.
- Mental health, cardiovascular, and metabolic disorder DTx solutions represent the largest growth segments in France.
- France's strategic position within Europe and emphasis on clinical validation drive competitive differentiation and market consolidation.
Digital Therapeutics/DTx Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | IMMERSIVE & INTERFACE-BASED THERAPEUTICS (Offering) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 26.4% from 2026 to 2031 |
| Largest Segment | B2B SALES CHANNELS (Sales Channel) |
| Market Size Base Year (Billions) | ~USD 10.96 (2026) |
| Revenue Forecast (Billions) | ~USD 35.37 (2031) |
| Segments Covered | Offering, Product Type, Application, Type, Revenue Model, Sales Channel, End User |
France Digital Therapeutics/DTx Market Report Segmentation
7 segment dimensions are covered across the global market.
By Offering
- Immersive & Interface-Based Therapeutics
- Software/Platforms
- Therapeutic Programs
By Product Type
- Non-Prescription Digital Therapeutics
- Prescription Digital Therapeutics
By Application
- Preventive Applications
- Treatment & Care-Related Applications
By Type
- Cardiovascular Diseases
- Central Nervous System (Cns) Disorders
- Chronic Respiratory Diseases
- Diabetes
- Diagnostic & Rehabilitation Centers
- Hospitals
- Medication Adherence
- Musculoskeletal Disorders
- Nutrition & Lifestyle Management
- Obesity & Weight Management
- Other Healthcare Providers
- Other Preventive Applications
- Other Treatment & Care-Related Applications
- Prediabetes
- Private Payers
- Public Payers
- Rehabilitation & Patient Care
- Sleep Disorders
- Smoking Cessation
- Specialty Clinics
- Substance Use Disorders & Addiction Management
By Revenue Model
- Licensing (Enterprise/SaaS) Models
- Outcome-/Value-Based Models
- Subscription-Based Models
By Sales Channel
- B2B Sales Channels
- B2C Sales Channels
By End User
- Employers
- Healthcare Payers
- Healthcare Providers
- Other End Users
- Patients/Individuals
Target Audience
- DTx Companies & Developers : Evaluate France as a market entry or expansion opportunity, understand local demand drivers, competitive positioning, and regulatory requirements for digital therapeutic solutions.
- Healthcare Providers & Hospitals : Assess DTx adoption trends, patient demand, and clinical integration opportunities in France to enhance care delivery, improve outcomes, and optimize operational efficiency.
- Investors & Private Equity : Identify high-growth investment opportunities in France's DTx market, evaluate portfolio companies' market potential, and support strategic M&A and funding decisions.
- Pharmaceutical & MedTech Companies : Understand DTx market dynamics in France to inform digital health partnerships, complementary product strategies, and integrated care solution development.
- Healthcare Consultants & Advisors : Provide clients with authoritative France-specific market intelligence to support strategic planning, competitive analysis, and healthcare transformation initiatives.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation for France ($587.5M in 2026) with detailed 5-year forecasts to support investment decisions, business planning, and competitive positioning in this high-growth market.
- France-Specific Regulatory Insights : Understand France's unique regulatory environment, reimbursement policies, and healthcare system dynamics that directly impact DTx commercialization and market entry strategies.
- Competitive Landscape Analysis : Identify key players, market segments, and competitive dynamics specific to France to inform product development, partnership strategies, and market differentiation approaches.
- Investment & Expansion Planning : Leverage France-focused market intelligence to evaluate expansion opportunities, assess market potential, and make data-driven decisions for resource allocation and go-to-market strategies.
- Stakeholder Communication : Access credible, France-specific market data to support investor pitches, board presentations, and strategic communications with healthcare stakeholders and regulatory bodies.
Frequently asked questions
What is the projected market size for digital therapeutics in France by 2031?
France's DTx market is projected to reach $2,096.5 million by 2031, growing from $587.5 million in 2026 at a 29.0% CAGR.
What are the primary drivers of DTx market growth in France?
Key drivers include rising chronic disease prevalence, increasing smartphone adoption, progressive reimbursement policies, and France's commitment to digital health integration within its public healthcare system.
Which therapeutic areas show the strongest DTx adoption in France?
Mental health, cardiovascular disease management, and metabolic disorder treatment represent the largest and fastest-growing DTx segments in France.
How does France's DTx market growth compare to global trends?
France's 29.0% CAGR significantly exceeds the global DTx market CAGR of 26.4%, reflecting stronger regulatory support and healthcare system integration.
What regulatory factors support DTx adoption in France?
France's progressive digital health policies, established reimbursement pathways, and emphasis on clinical validation create a supportive regulatory environment for DTx market expansion.
RESEARCH METHODOLOGY
This research study involved the extensive use of both primary and secondary sources. It involved the analysis of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.
Secondary Research
This research study extensively utilized secondary sources, including directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, as well as white papers, annual reports, and companies' house documents. The secondary research aimed to gather and analyze information for a comprehensive and commercially focused study of the digital therapeutics market, encompassing technical aspects and market dynamics. It also facilitated the identification of key players, market classification, industry trends, geographical markets, and significant market-related developments. Additionally, a database of prominent industry leaders was compiled through secondary research.
Primary Research
In the primary research process, various supply-side and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the digital therapeutics market. Primary sources from the demand side included personnel from healthcare providers, payers, employees, and patients/individuals.
Others include sales managers, marketing managers, and product managers.
Note: Tiers are defined based on a company’s total revenue, as of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the digital therapeutics market was determined after data triangulation through the two approaches mentioned below. After the completion of each approach, the weighted average of these approaches was taken based on the level of assumptions used in each approach.
Global Digital Therapeutics Market Size: Top-down Approach and Bottom-up Approach
Data Triangulation
The size of the digital therapeutics market was estimated through segmental extrapolation using the bottom-up approach. The methodology used is as given below:
- Revenues for individual companies were gathered from public sources and databases.
- Shares of leading players in the digital therapeutics market were gathered from secondary sources to the extent available. In certain cases, shares of digital therapeutics businesses have been ascertained after a detailed analysis of various parameters, including product portfolios, market positioning, selling price, and geographic reach & strength.
- Individual shares or revenue estimates were validated through interviews with experts.
- The total revenue in the digital therapeutics market was determined by extrapolating the market share data of major companies.
Market Definition
The digital therapeutics market comprises evidence-based, clinically validated software solutions designed to prevent, manage, or treat medical conditions through therapeutic interventions delivered via digital technologies. These solutions are delivered through mobile applications, web-based platforms, connected devices, and immersive technologies, and may be prescribed by healthcare professionals or accessed directly by consumers. By leveraging data analytics, artificial intelligence (AI), and personalized behavioral interventions, digital therapeutics improve clinical outcomes, enhance patient engagement, and support the prevention and management of acute and chronic diseases.
Key Stakeholders
- Digital therapeutics developers and platform providers
- Pharmaceutical and biotechnology companies
- Healthcare providers (hospitals, specialty clinics, rehabilitation centers, and primary care centers)
- Health insurance companies (public and private payers)
- Employers and corporate wellness providers
- Medical device and wearable technology companies
- Academic medical centers, universities, and research institutions
- Regulatory agencies and health technology assessment (HTA) bodies
- Government and public health organizations
- Telehealth and digital health platform providers
- Electronic health record (EHR) and healthcare IT solution providers
- Investors, venture capital firms, and private equity firms
- Patients and patient advocacy organizations
- Business research and consulting service providers
Report Objectives
- To define, describe, and forecast the digital therapeutics market based on offering, product type, application, revenue model, sales channel, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall digital therapeutics market
- To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and analyze their market shares and core competencies
- To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, and collaborations in the overall digital therapeutics market
- To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific digital therapeutics market into Taiwan, New Zealand, Thailand, Singapore, Malaysia, and other countries
- Further breakdown of the Rest of Europe digital therapeutics market into Russia, Austria, Finland, Sweden, Turkey, Norway, Poland, Portugal, Romania, Denmark, and other countries
Get the Full Digital Therapeutics/DTx Market Report
Full forecast, segment splits, and company analysis for all Digital Therapeutics/DTx Market.
- US Digital Therapeutics/DTx Market
- Canada Digital Therapeutics/DTx Market
- Germany Digital Therapeutics/DTx Market
- UK Digital Therapeutics/DTx Market
- Italy Digital Therapeutics/DTx Market
- Spain Digital Therapeutics/DTx Market
- China Digital Therapeutics/DTx Market
- Japan Digital Therapeutics/DTx Market
- India Digital Therapeutics/DTx Market
- Australia Digital Therapeutics/DTx Market
- South Korea Digital Therapeutics/DTx Market
- Brazil Digital Therapeutics/DTx Market
- Mexico Digital Therapeutics/DTx Market
- Saudi Arabia Digital Therapeutics/DTx Market
- UAE Digital Therapeutics/DTx Market
- South Africa Digital Therapeutics/DTx Market
- Rest Of Europe Digital Therapeutics/DTx Market
- Rest Of Asia Pacific Digital Therapeutics/DTx Market
- Rest Of Latin America Digital Therapeutics/DTx Market
- GCC Countries Digital Therapeutics/DTx Market
- Rest Of GCC Countries Digital Therapeutics/DTx Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
